Companies → Amgen Inc.
Amgen Inc.
United States, California, Thousand Oaks
Updated Jul 18, 2024 10:31
Description
Amgen is among the most significant biotechnology companies committed to unlocking biology's potential for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Its main products with the most significant annual commercial sales, are ENBREL, Prolia, Neulasta, Otezla, XGEVA, Aranesp, KYPROLIS, and Repatha. Amgen's products are marketed worldwide, with the US market accounting for about 70% of revenue.
Address:
1 Amgen Center Dr Thousand Oaks
CA
91320-1799 United States
Website:
Revenue
$26320M
Company is likely to sell
- Enbrel
- Prolia
- Neulasta
- Otezla
- Xgeva
- Aranesp
- Kyprolis
- Repatha
- Pharmaceutical preparations
- Chemical products
- Human therapeutics
- Medicines
- Innovative drugs
- Healthcare products
- Immunology products
- Cancer treatments
- Bone health products
- Cardiovascular drugs
- Chronic disease medications
- Therapeutic antibodies
- Oncology drugs
- Rheumatology treatments
- Hematology products
- Neurology medications
- Respiratory therapies
- Dermatology products
- Gastroenterology drugs
- Biotechnology products
- Biological products
- Biopharmaceuticals
Disclaimer:
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.